Literature DB >> 19320862

Prospective observational study of low thresholds for platelet transfusion in adult dengue patients.

Laurent Thomas1, Stéphane Kaidomar, Brigitte Kerob-Bauchet, Victor Moravie, Yannick Brouste, Jean Philippe King, Sarah Schmitt, François Besnier, Sylvie Abel, Hossein Mehdaoui, Yves Plumelle, Fatiha Najioullah, Christiane Fonteau, Pascale Richard, Raymond Césaire, André Cabié.   

Abstract

BACKGROUND: The practice of platelet (PLT) transfusions has been adopted into the standard clinical practice in many dengue-endemic countries. Because many patients were found to have received unnecessary PLT transfusions, the development of guidelines for the management of dengue patients with thrombocytopenia has become a necessity. STUDY DESIGN AND METHODS: An emergency department-based prospective observational study was conducted in Martinique during a dengue outbreak in adult patients presenting with an acute febrile illness. Patients with severe bleeding and/or who underwent invasive intensive care procedures or emergency surgery were given PLT transfusion to achieve PLT counts of more than 50 x 10(9)/L. PLT transfusion was also considered for patients with PLT counts of less than 5 x 10(9)/L and for those with associated risk factors and PLT counts of less than 20 x 10(9)/L.
RESULTS: A total of 350 patients were admitted with confirmed dengue infections. Most of them had secondary serotype-2 infections. PLT counts of less than 50 x 10(9)/L were recorded in 165 patients (47.1%). PLT transfusion was administered to 9 patients with thrombocytopenia. The indications included severe bleeding (5 cases), invasive procedures (3 cases), emergency surgery (1 case), and/or associated risk factors (2 cases). The median time duration from the onset of fever to PLT transfusion was 6 days (range, 4-10 days). The median amount of PLTs transfused was 3.66 x 10(11) (range, 2.8 x 10(11)-13.2 x 10(11)). The median PLT yield was +12.4% (range, -3.9% to +67.1%). Three patients died. All other patients recovered during the second week after the onset of fever.
CONCLUSION: A restrictive strategy for PLT transfusion based on clinical features and low PLT count thresholds proved to be feasible and safe for adult dengue patients.

Entities:  

Mesh:

Year:  2009        PMID: 19320862     DOI: 10.1111/j.1537-2995.2009.02132.x

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  9 in total

1.  Prophyactic platelet transfusion in stable dengue Fever patients: is it really necessary?

Authors:  B Prashantha; S Varun; Damodar Sharat; B V Murali Mohan; R Ranganatha; Manchal Naveen
Journal:  Indian J Hematol Blood Transfus       Date:  2013-03-07       Impact factor: 0.900

2.  Simultaneous Detection of Dengue NS1 Antigen, IgM plus IgG and Platelet Enumeration during an Outbreak.

Authors:  Subhash C Arya; Nirmala Agarwal; Satibh C Parikh; Shekhar Agarwal
Journal:  Sultan Qaboos Univ Med J       Date:  2011-10-25

3.  Clinical profile of concurrent dengue fever and Plasmodium vivax malaria in the Brazilian Amazon: case series of 11 hospitalized patients.

Authors:  Belisa M L Magalhães; Márcia A A Alexandre; André M Siqueira; Gisely C Melo; João B L Gimaque; Michele S Bastos; Regina M P Figueiredo; Ricardo C Carvalho; Michel A Tavares; Felipe G Naveca; Pedro Alonso; Quique Bassat; Marcus V G Lacerda; Maria P G Mourão
Journal:  Am J Trop Med Hyg       Date:  2012-10-01       Impact factor: 2.345

4.  Clinical features of dengue in a large Vietnamese cohort: intrinsically lower platelet counts and greater risk for bleeding in adults than children.

Authors:  Dinh The Trung; Le Thi Thu Thao; Nguyen Minh Dung; Tran Van Ngoc; Tran Tinh Hien; Nguyen Van Vinh Chau; Marcel Wolbers; Dong Thi Hoai Tam; Jeremy Farrar; Cameron Simmons; Bridget Wills
Journal:  PLoS Negl Trop Dis       Date:  2012-06-26

5.  Direct costs of dengue hospitalization in Brazil: public and private health care systems and use of WHO guidelines.

Authors:  Alessandra A Vieira Machado; Anderson Oliveira Estevan; Antonio Sales; Kelly Cristina da Silva Brabes; Júlio Croda; Fábio Juliano Negrão
Journal:  PLoS Negl Trop Dis       Date:  2014-09-04

6.  Clinical and laboratory characteristics of patients with dengue hemorrhagic fever manifestations and their transfusion profile.

Authors:  Denys Eiti Fujimoto; Sergio Koifman
Journal:  Rev Bras Hematol Hemoter       Date:  2014-03

7.  Physician survey to determine how dengue is diagnosed, treated and reported in puerto rico.

Authors:  Kay M Tomashek; Brad J Biggerstaff; Mary M Ramos; Carmen L Pérez-Guerra; Enid J Garcia Rivera; Wellington Sun
Journal:  PLoS Negl Trop Dis       Date:  2014-10-09

8.  Potential Harm of Prophylactic Platelet Transfusion in Adult Dengue Patients.

Authors:  Tau-Hong Lee; Joshua G X Wong; Yee-Sin Leo; Tun-Linn Thein; Ee-Ling Ng; Linda K Lee; David C Lye
Journal:  PLoS Negl Trop Dis       Date:  2016-03-25

Review 9.  Dengue therapeutics, chemoprophylaxis, and allied tools: state of the art and future directions.

Authors:  James Whitehorn; Sophie Yacoub; Katherine L Anders; Louis R Macareo; M Cristina Cassetti; Vinh Chau Nguyen Van; Pei-Yong Shi; Bridget Wills; Cameron P Simmons
Journal:  PLoS Negl Trop Dis       Date:  2014-08-28
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.